Market News
Stay updated with the latest market trends, earnings, and economic indicators.
The $1 trillion AI 'arms race' is fueling a hidden supercycle and it's not just chips
DBS Bank says the global AI arms race is driving a multi-year capex supercycle extending beyond semiconductors into energy, networking, infrastructure and data centres. The bank expects AI spending, sovereign AI investments and rising power demand to create new investment opportunities while reshaping portfolio allocation amid persistent inflation and geopolitical risks.
Corporate giants turn to urban regeneration as redevelopment race intensifies
India's largest corporate houses are increasingly focusing on urban regeneration, shifting real estate focus from land acquisition to redevelopment. Giants like Reliance, Adani and JSW are aggressively bidding for projects involving old housing colonies and slum rehabilitation in Mumbai.
Google Puts Brakes On Meta's Gemini AI Usage Over Capacity Shortfall
The reported restrictions come as tech companies race to secure computing power to fuel growing artificial intelligence ambitions.
Iran war triggers global race to build oil reserves
Vulnerable nations, stung by the Iran war's economic fallout, are boosting oil and gas storage to weather future crises. This global push for reserves could add half a billion barrels of demand. Countries like India and Pakistan are prioritizing stockpiles, learning from China's successful strategy of reducing imports during supply disruptions. This move aims to prevent severe economic distress and insulate economies from volatile energy markets.
The conviction in India continues to be very high: Citi's Achintya Mangla
India is a significant market for Citi, with growth expected in AI, energy, and data-center infrastructure. Foreign investors are currently cautious, questioning India's position in the global AI race and seeking improvements in ease of doing business. Despite short-term volatility, long-term conviction in India remains strong, supported by favorable demographics and growing manufacturing.
INOXGFL leads race for Vena's India biz buyout; Proposed deal may give Rs 4,500-5,000 crore enterprise value
INOXGFL Group is poised to acquire Vena Energy's Indian renewable energy business. The deal is valued between ₹4,500-5,000 crore. This move signifies INOXGFL's aggressive expansion in India's clean energy sector. The conglomerate has recently made several strategic acquisitions, bolstering its renewable energy portfolio. This acquisition further strengthens its position in the rapidly growing market.
Aditya Birla group, KKR left in race for Sprng Energy
Aditya Birla Group and KKR are vying to buy Shell's renewable energy firm Sprng Energy. Binding financial bids are in, and Shell will negotiate with the top two contenders next week. India's National Investment and Infrastructure Fund and Actis are out of the running. The deal could be worth around $2 billion. Shell is reviewing strategic options for Sprng Energy.
Morgan Stanley warns oil market in ‘race against time’ as Strait of Hormuz remains shut amid Iran war
Morgan Stanley warned that global oil markets are in “a race against time” as prolonged disruption in the Strait of Hormuz could sharply tighten supplies and push crude prices higher. Analysts said current market buffers may weaken if the closure extends into late June or July, raising risks for global energy markets.
Racing driver Jehan Daruvala changes lanes, joins Sterling and Wilson Group to redefine his 'fast track' career
The fourth-generation scion, 27, has swapped race suits for a corporate role, embracing a new kind of 'fast track' by securing deals and driving projects in his family's growing renewable energy and data centre empire.
Kridhan Infra Ltd leads losers in 'B' group
Finkurve Financial Services Ltd, Race Eco Chain Ltd, Vaswani Industries Ltd and InfoBeans Technologies Ltd are among the other losers in the BSE's 'B' group today, 02 March 2026.
How Shaily Engineering is riding the semaglutide wave to outshine the market
As patents for weight-loss drug expire — from India to Canada and Brazil — generic drugmakers are rushing to launch alternatives. And in that race, Shaily has emerged as a critical partner